{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:3cfe232a-2cb0-4507-bcf2-0ffc2b37605c", "type": "composite", "version": "1", "versioncreated": "2026-10-21T09:00:37.118813Z", "firstcreated": "2026-10-21T09:00:37.118813Z", "pubstatus": "usable", "language": "en", "headline": "OpenAI Acquires Orchestra Bio to Build AI Agents for Drug Development", "description_text": "OpenAI is acquiring startup Orchestra Bio and will merge it with its life sciences platform Rosalind to build AI agents that help pharmaceutical teams coordinate drug development, from tracking trials to spotting problems.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a4c83f30-5d84-4aae-a3c2-6cd725f45c19", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-21T09:05:17.445883Z", "firstcreated": "2026-10-21T09:00:37.118813Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "OpenAI Acquires Orchestra Bio to Build AI Agents for Drug Development", "byline": "Katharina Neumann", "located": "Germany", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Hochland", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "OpenAI is acquiring startup Orchestra Bio and will merge it with its life sciences platform Rosalind to build AI agents that help pharmaceutical teams coordinate drug development, from tracking trials to spotting problems.", "altids": {"mosaic": "a4c83f30-5d84-4aae-a3c2-6cd725f45c19", "story": "3cfe232a-2cb0-4507-bcf2-0ffc2b37605c", "slug": "openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development"}, "subject": [{"name": "Technology", "rel": "direct", "literal": "technology", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "Germany", "literal": "de", "code": "DE", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "OpenAI is acquiring startup Orchestra Bio and will merge it with its life sciences platform Rosalind to build AI agents that help pharmaceutical teams coordinate drug development, from tracking trials to spotting problems.", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:5dadb14c-a4ad-4169-8449-dba61ad32461", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "OpenAI acquires Orchestra Bio to build AI agents that speed up drug development", "description_text": "OpenAI Acquires Orchestra Bio to Build AI Agents for Drug Development", "copyrightholder": "the-decoder.com", "copyrightnotice": "OpenAI acquires Orchestra Bio to build AI agents that speed up drug development", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "5dadb14c-a4ad-4169-8449-dba61ad32461"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-10-21T09:05:17.466129Z", "attribution_required": true, "attribution_text": "OpenAI acquires Orchestra Bio to build AI agents that speed up drug development", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "the-decoder.com", "source_url": "https://the-decoder.com/wp-content/uploads/2026/10/openai_orchestra_bio.png", "source_page_url": "https://the-decoder.com/wp-content/uploads/2026/10/openai_orchestra_bio.png", "our_page_url": "https://hochland.uno/technology/openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://the-decoder.com/wp-content/uploads/2026/10/openai_orchestra_bio.png", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:3cfe232a-2cb0-4507-bcf2-0ffc2b37605c", "slug": "openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development-20261021", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Hochland", "canonical_required": true, "canonical_url": "https://hochland.uno/technology/openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "single_source", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "failed", "score": 0.795, "checked_at": "2026-10-21T09:05:17.462828Z"}, "sources": [{"url": "https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/", "title": "OpenAI acquires Orchestra Bio to build AI agents that speed up drug development", "publisher": "the-decoder.com", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-10-21T09:05:17.453215Z", "published_at": "2026-10-21T07:32:54Z"}]}, "wireva:publication": {"name": "Hochland", "domain": "hochland.uno", "country": "DE", "url": "https://hochland.uno/technology/openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a4c83f30-5d84-4aae-a3c2-6cd725f45c19", "html": "https://wireva.mib.news/item/a4c83f30-5d84-4aae-a3c2-6cd725f45c19/openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development/", "story": "https://wireva.mib.news/story/openai-acquires-orchestra-bio-to-build-ai-agents-for-drug-development-20261021/"}, "wireva:metrics": {"word_count": 459, "char_count": 3071, "reading_time_seconds": 219}}}}, "extra": {"wireva:languages": ["en"], "wireva:status": "developing", "wireva:item_count": 1}}